Statins May Not Be Effective As We Thought

Statins, the favored cholesterol-fighting treatment, won’t be as efficient as beforehand believed in defending seniors with no historical past of coronary heart illness, based on a research printed Monday.

NYU Langone Medical Center researchers checked out 2,867 wholesome older adults who had been taking statins and located no proof to recommend they had been dwelling any longer because of this.

This was printed in JAMA Internal Medicine.

Statins are bought below the generic identify Pravastatin and below model names resembling Lipitor, Crestor and Zocor.

“Our study argues that the benefits of initiating statins in older patients, particularly those over 75, may not outweigh the risks,” stated lead creator Dr. Benjamin Han.

Potential uncomfortable side effects of statins embody muscle ache, liver injury and elevated threat of Type 2 diabetes, based on the Mayo Clinic.

“As the number of older adults in the United States is rapidly increasing, it is more important than ever that we improve our understanding of preventative interventions in aging patients, and the possible side effects and risks that accompany them,” Han stated.

Reps for the makers of Lipitor and Zocor couldn’t be instantly reached for touch upon Monday.

A spokeswoman for Crestor’s maker AstraZeneca stated: “The safety and efficiency of Crestor has been well established in more than 120 ongoing or completed clinical trials involving more than 67,000 patients worldwide over the past 13 years.”